Thrombologic ApS
🇩🇰Denmark
Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
Phase 2
Terminated
- Conditions
- Pneumonia
- Interventions
- Drug: low molecular weight heparin.
- First Posted Date
- 2012-02-14
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- Thrombologic ApS
- Target Recruit Count
- 5
- Registration Number
- NCT01532544
- Locations
- 🇩🇰
Vejle hospital, Vejle, Denmark
🇩🇰University hospital Copenhagen, Copenhagen, Denmark
🇫🇮Kuopio University Hospital, Kuopio, Finland
Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)
Phase 1
Completed
- Conditions
- Myocardial Infarct
- Interventions
- First Posted Date
- 2010-08-11
- Last Posted Date
- 2011-06-02
- Lead Sponsor
- Thrombologic ApS
- Target Recruit Count
- 16
- Registration Number
- NCT01179776
- Locations
- 🇩🇰
Lene Holmvang, Copenhagen, Denmark
© Copyright 2025. All Rights Reserved by MedPath